Hartmann, Arndt

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Denkert, C., von Minckwitz, G., Darb-Esfahani, S., Lederer, B., Heppner, B. I., Weber, K. E., Budczies, J., Huober, J., Klauschen, F., Furlanetto, J., et al. (2018) · The Lancet Oncology

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 2,157

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Pagès, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C., Lugli, A., Zlobec, I., Rau, T. T., Berger, M. D., et al. (2018) · The Lancet

Cancer Immunotherapy and BiomarkersColorectal Cancer Surgical Treatments

Cited by 2,075

Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer

Foersch, S., Glasner, C., Woerl, A.-C., Eckstein, M., Wagner, D.-C., Schulz, S., Kellers, F., Fernandez, A., Tserea, K., Kloth, M., et al. (2023) · Nature Medicine

AI in cancer detectionCancer Immunotherapy and Biomarkers

Cited by 251

IL-9 and its receptor are predominantly involved in the pathogenesis of UC

Nalleweg, N., Chiriac, M. T., Podstawa, E., Lehmann, C., Rau, T. T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015) · Gut

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 181

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer

Echarti, A., Hecht, M., Büttner-Herold, M., Haderlein, M., Hartmann, A., Fietkau, R., & Distel, L. (2019) · Cancers

Cancer Immunotherapy and BiomarkersHead and Neck Cancer Studies

Cited by 87

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

Gass, P., Lux, M. P., Rauh, C., Hein, A., Bani, M. R., Fiessler, C., Hartmann, A., Häberle, L., Pretscher, J., Erber, R., et al. (2018) · BMC Cancer

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 83

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors

Heger, L., Hatscher, L., Liang, C., Lehmann, C. H. K., Amon, L., Lühr, J. J., Kaszubowski, T., Nzirorera, R., Schaft, N., Dörrie, J., et al. (2023) · Proceedings of the National Academy of Sciences

Immunotherapy and Immune ResponsesImmune Response and Inflammation

Cited by 54

Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity

Posselt, R., Erlenbach-Wünsch, K., Haas, M., Jeßberger, J., Büttner-Herold, M., Haderlein, M., Hecht, M., Hartmann, A., Fietkau, R., & Distel, L. V. (2016) · Oncotarget

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 38

Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: Comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort

Kullmann, F., Strissel, P. L., Strick, R., Stoehr, R., Eckstein, M., Bertz, S., Wullich, B., Sikic, D., Wach, S., Taubert, H., et al. (2023) · Journal of Clinical Pathology

Genetic factors in colorectal cancerBladder and Urothelial Cancer Treatments

Cited by 20